John Rublein
Impact in
- Virology top 5%
- HIV Research and Treatment
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 6
- HIV/AIDS Research and Interventions 3
- Viral Infections and Vectors 1
-
- HIV-related health complications and treatments 3
- Co-authors
- Ralph H. Raasch (6 shared papers)Scott R. Smith (1 shared paper)Margaret A. Chesney (1 shared paper)Tina Penick Brock (1 shared paper)Cheryl Marcus (2 shared papers)Joseph J. Eron (3 shared papers)Naser L. Rezk (2 shared papers)Angela D. M. Kashuba (2 shared papers)
- Journals
- Annals of Pharmacotherapy (5 papers)American Journal of Health-System Pharmacy (3 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (1 paper)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (1 paper)Clinical Trials (1 paper)
- Partner nations
- United StatesUnited KingdomIndia
In The Last Decade
John Rublein
16 papers receiving 511 citations
Peers
Comparison fields: 5 of 88
- Virology 98
- Infectious Diseases 272
- Emergency Medicine 96
- Family Practice 15
- Pharmacology 61
Countries citing papers authored by John Rublein
This map shows the geographic impact of John Rublein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Rublein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Rublein more than expected).
Fields of papers citing papers by John Rublein
This network shows the impact of papers produced by John Rublein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Rublein. The network helps show where John Rublein may publish in the future.
Co-authors
The 25 scholars most cited alongside John Rublein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 167 | |
| 2 | 2003 | 105 | |
| 3 | 2000 | 65 | |
| 4 | 2004 | 51 | |
| 5 | 2004 | 34 | |
| 6 | 2003 | 29 | |
| 7 | 2004 | 23 | |
| 8 | 2008 | 23 | |
| 9 | 2002 | 19 | |
| 10 | 1999 | 12 | |
| 11 | 2014 | 7 | |
| 12 | 2017 | 6 | |
| 13 | 2004 | 3 | |
| 14 | 1998 | 2 | |
| 15 | 2002 | 2 | |
| 16 | 2004 | 2 | |
| 17 | 2018 | 0 |
About John Rublein
John Rublein is a scholar working on Infectious Diseases, Emergency Medicine, Parasitology, Pharmacology and Applied Microbiology and Biotechnology, having authored 17 papers that have together received 550 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (6 papers), HIV/AIDS Research and Interventions (3 papers), HIV-related health complications and treatments (3 papers), Vector-borne infectious diseases (2 papers), Antibiotics Pharmacokinetics and Efficacy (1 paper), Pharmacovigilance and Adverse Drug Reactions (1 paper), Viral Infections and Vectors (1 paper) and Pneumonia and Respiratory Infections (1 paper). The work is most often cited by research in Virology (98 citations), Infectious Diseases (272 citations), Emergency Medicine (96 citations), Family Practice (15 citations) and Pharmacology (61 citations). John Rublein has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include Ralph H. Raasch, Scott R. Smith, Margaret A. Chesney, Tina Penick Brock, Cheryl Marcus, Joseph J. Eron, Naser L. Rezk, Angela D. M. Kashuba, Rosa F. Yeh and Kristine B. Patterson. Their work appears in journals such as Annals of Pharmacotherapy, American Journal of Health-System Pharmacy, JAIDS Journal of Acquired Immune Deficiency Syndromes, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy and Clinical Trials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.